MIZUHO MARKETS AMERICAS LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1825516 NEW YORK, NY

Position in HALO

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$85,540,648

+$158,956 QoQ

Shares Held

1,323,544

+4.3% QoQ

Ownership

1.12%

of shares outstanding

% of Portfolio

2.58%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

15 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MIZUHO MARKETS AMERICAS LLC holds $98,260,494 across 2 Biotechnology names. HALO ranks #1 (87.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	HALO	Halozyme Therapeutics, Inc. This page	1,323,544	$85,540,648
2	BBIO	BridgeBio Pharma, Inc.	171,288	$12,719,846

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$85,540,648	1,323,544	+4.3%	Shares	Defined	2026-05-14
2025-12-31	$85,381,692	1,268,673	+270.8%	Shares	Defined	2026-02-06
2025-09-30	$25,093,060	342,147	-13.9%	Shares	Defined	2025-10-29
2025-06-30	$20,669,262	397,333	+6.2%	Shares	Defined	2025-08-01
2025-03-31	$23,875,979	374,173	-19.9%	Shares	Defined	2025-05-12
2024-12-31	$22,340,800	467,283	+24.5%	Shares	Defined	2025-02-11
2024-09-30	$21,490,529	375,446	-14.3%	Shares	Defined	2024-11-06
2024-06-30	$22,939,230	438,106	-4.1%	Shares	Defined	2024-07-31
2024-03-31	$18,575,952	456,636	+2.2%	Shares	Defined	2024-05-10
2023-12-31	$16,508,590	446,661	+10.9%	Shares	Defined	2024-02-08
2023-09-30	$15,381,726	402,663	-0.0%	Shares	Defined	2023-11-09
2023-06-30	$14,528,382	402,783	+12.1%	Shares	Defined	2023-08-09
2023-03-31	$13,717,198	359,183	+30.5%	Shares	Defined	2023-05-12
2022-12-31	$15,662,749	275,268	-23.3%	Shares	Defined	2023-02-03
2022-09-30	$14,183,709	358,718	—	Shares	Defined	2022-10-24
No filing history on record for this holder in this stock.